NCT02048839

Brief Summary

SUBJECTS: All participants in the RADIEL-study (2008-2011) who delivered (n=535), will be invited to this follow-up study, with their children (age 3-5 years) and the father. The investigations are carried out during two separate visits. The father receives mail questionnaires OVERALL OBJECTIVES:

  1. 1.To determine the long-term effectiveness of a lifestyle intervention in high risk women and their offspring a in reducing the incidence of T2DM and cardiovascular disease and their risk factors b in preventing obesity c on biomarkers d on genetic and epigenetics markers .
  2. 2.To study the association between maternal diet during pregnancy and metabolic markers in the offspring at age 3-5 years.
  3. 3.To study the association between maternal exercise habits during pregnancy and metabolic markers in the offspring at age 3-5 years.
  4. 4.To study the association between maternal a) glucose-insulin metabolism b) lipid metabolism c) adipoinsulinar axis and d) inflammatory markers and birth size and later health outcomes in the mothers and their offspring.
  5. 5.To study the association between gut microbiota and markers of offspring health
  6. 6.To study associations between offspring cardiovascular morphology/function, offspring body size/composition, and maternal cardiovascular risk
  7. 7.To study the cost effectiveness of the intervention.
  8. 8.Height, weight, waist and hip circumference
  9. 9.Blood pressure, pulse
  10. 10.Body fat percentage
  11. 11.Blood tests e.g. markers of glucose metabolism and lipids, vitamin D, Calcium and bone markers, DNA sample and inflammation markers
  12. 12.Fecal and hair samples
  13. 13.Diurnal salivary cortisol assessment
  14. 14.Background questionnaire: socioeconomic and health-related background
  15. 15.Health-related quality of life (15-D).
  16. 16.3-day food diary and exercise diary
  17. 17.ArmBand (acceleration sensor), assessment of physical activity and sleep for 7 days
  18. 18.Psychological questionnaires
  19. 19.Pulse wave velocity (PWV) will be assessed
  20. 20.Advanced glycation endproducts - a marker of cardiovascular health will be assessed
  21. 21.Dental and oral health
  22. 22.Bone health
  23. 23.VHRU of arterial structure
  24. 24.Background questionnaire (incl. height, weight, age)
  25. 25.DNA-sample (buccal)
  26. 26.3-day food diary
  27. 27.Psychological questionnaires
  28. 28.Physical activity questionnaire (12 months)
  29. 29.Body weight, height, blood pressure, pulse
  30. 30.Body fat percentage
  31. 31.Psychological questionnaires
  32. 32.Food and physical activities diaries
  33. 33.ActiGraph, assessment of physical activity and sleep for 7 days
  34. 34.Blood samples e.g. glucose- and insulin metabolism, lipids, vitamin D and calcium metabolism, DNA-sample and samples for inflammation markers
  35. 35.Fecal, urine and hair samples
  36. 36.A copy of child welfare center card (e.g. data on growth, immunizations, health)
  37. 37.Endothelial function and pulse wave velocity (PWV)
  38. 38.Bone health with peripheral CT
  39. 39.Heart structure and function
  40. 40.VHRU of arterial structure

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
680

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

January 27, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 29, 2014

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2017

Completed
Last Updated

April 16, 2019

Status Verified

April 1, 2019

Enrollment Period

3.6 years

First QC Date

January 27, 2014

Last Update Submit

April 15, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Type 2 Diabetes

    3-5 years post partum

Secondary Outcomes (1)

  • Metabolic syndrome and cardiovascular morbidity

    3-5 years post partum

Other Outcomes (1)

  • Obesity

    3-5 years post partum

Study Arms (2)

Radiel Intervention group and their children

Participated the Radiel- intervention study (2008-2011) in the Intervention group: Lifestyle counselling during and after pregnancy (up to 1 year post partum)

Radiel Control Group with their children

Control group in the Radiel- intervention study.

Eligibility Criteria

Age3 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women who participated the Radiel intervention study, and were originally randomly assigned to either active lifestyle intervention group or control group. They were all high risk women with BMI \>30 or prior gestational GDM. To this follow up-study we invite also the children born during the intervention.

You may qualify if:

  • all study subjects form Radiel intervention study, who delivered a baby

You may not qualify if:

  • none.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Helsinki University

Helsinki, Finland

Location

Biospecimen

Retention: SAMPLES WITH DNA

Blood, saliva, hair, urine and fecal samples

MeSH Terms

Conditions

Diabetes Mellitus, Type 2ObesityMetabolic Syndrome

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsInsulin ResistanceHyperinsulinism

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD

Study Record Dates

First Submitted

January 27, 2014

First Posted

January 29, 2014

Study Start

January 1, 2014

Primary Completion

August 1, 2017

Study Completion

August 1, 2017

Last Updated

April 16, 2019

Record last verified: 2019-04

Locations